Cognitive Training After Stroke : Effects and Mechanisms
Kognitiv Trening Etter Hjerneslag: Effekter og Mekanismer #2015/1282
Stroke is a major cause of severe cognitive and physical disability. Despite the high and increasing incidence, and large health, economic, social and personal consequences, studies designed to remedy cognitive impairments and improve rehabilitation care following stroke are lacking. A promising line of research have shown that weak electrical current (tDCS) can be a safe, cost-effective, and potent treatment when combined with other rehablitational approaches.
The underlying mechanism is assumed that tDCS facilitates neuronal signaling, improving plasticity and facilitating rehablitational outcome. But further research is needed to better understand the mechanisms at hand, and to better evaluate the potential clinical utility.
The scope for the current project is to investigate both cognitive and neuronal effects of tDCS in combination with cognitive training , with the ultimate goal to improve current rehabilitational healthcare. To achieve this we will use multimodal MRI, EEG, and a comprehensive battery of neuropsychological asessment, to describe and evaluate the effect of tDCS in rehabilitation purposes.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Participants are randomly assigned to either active or sham condition, using codes provided by the manufacturer and implemented by an in-house Matlab script, pseudo-randomizing participants while maintaining balance in groups of 20. tDCS stimulation is applied at six occasions for each participant, with a minimum of 48 hours between stimulations, aiming at an average of two stimulations per week. Stimulation current is1000 μA, stimulation time was 20 min for the active group with a ramp-up time of 120 s and fade-out time of 30 s. The current intensity is limited to 1 mA to limit the risk of adverse events due to the electrical stimulation. The sham stimulation consists of ramp-up followed by 40 s of active stimulation and then fade-out, following factory settings.
Cognitive training will be done by the computerized working memory training program (Cogmed Systems AB, Stockholm, Sweden) consisting of 25 online training sessions. In this study, to increase feasibility, we utilize 17 sessions over a period of three to four weeks, corresponding to approximately five weekly training sessions. On average, we aim at two training sessions combined with tDCS per week with a minimum of one day between each tDCS session. The remaining CCT sessions are performed at home.
Neuropsychological assessments and MRI assessments are conducted three times: at baseline 1, after a waiting period of 2-4 weeks (baseline 2, before intervention) and immediately post intervention. Self-reported symptoms of fatigue and depression are assessed at five time points, before, during and after completing intervention.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Oslo, Norvège
- Oslo University Hospital
-
Oslo, Norvège
- Oslo University Hospital Ullevål
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- MR/CT revealing ischemic or hemorrhagic damage (stroke).
Exclusion Criteria:
- History of illness or damage to the CNS, besides stroke.
- <18 years of age
- Extensive cognitive decline or dementia
- Severe psychiatric disorders
- Substance or alcohol abuse
- Contraindications for MRI.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Tripler
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Active stimulation
Participants recieving active trancranial direct current stimulation (tDCS) Parameters: 20 minutes anodal tDCS 1mA.
Two times a week, for three weeks.
Anode placed at F3, cathode placed at right cerebellum.
|
|
|
Comparateur placebo: Sham stimulation
Participants recieving passive / sham trancranial direct current stimulation (tDCS) Two times a week, for three weeks.
Anode placed at F3, cathode placed at right cerebellum.
|
Sham Transcranial direct current stimulation (tDCS)
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Evidence of change in neural activity in attentional-related brain areas after receiving anodal tDCS, as measured with functional MRI
Délai: One and a half year
|
Change in activation patterns during multiple object tracking (MOT) at first baseline, before initiating training (second baseline, on average 4 weeks after baseline measure), and after a three-week intervention (post-intervention assessment)
|
One and a half year
|
|
Evidence of structural changes after receiving anodal tDCS, as measured with structural MRI
Délai: One and a half year
|
Structural MRI
|
One and a half year
|
|
Evidence of increased attentional and working memory capacity after receiving anodal tDCS
Délai: One and a half year
|
Rate of improvement in Cogmed tasks
|
One and a half year
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Evidence of increased attentional capacity after receiving anodal tDCS
Délai: One and a half year
|
Performance change in The Theory of Visual Attention (TVA) computerized paradigm.
|
One and a half year
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Evidence of change in fatigue severity after receiving tDCS
Délai: One and a half year
|
Fatigue Severity Scale (FSS), a seven-point Likert scale on subjective fatigue severity/impact.
9 items scored from 1 (less symptoms) to 7 (most severe symptoms).
Scores are reported as mean scores, lowest possible mean = 1, highest possible mean = 7.
|
One and a half year
|
|
Evidence of change in symptoms of depression after receiving tDCS
Délai: One and a half year
|
Patient Health Questionnaire (PHQ-9), self-reported depressive symptoms.
Scale consists of 9 items, scored from 0 (not at all) to 3 (nearly every day).
Scores are reported as sum scores, range 0 (less symptoms) - 27 (more symptoms)
|
One and a half year
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Directeur d'études: Lars T. Westlye, Ph.D, University of Oslo
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2015/1282
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .